Seeing Is Believing
with an average price target of $26.89. This is a potential upside of $26.89 (0%) from yesterday's end of day stock price of $0.
Global Blood Therapeutics's activity chart (see below) currently has 185 price targets and 105 ratings on display.
Analysts average stock forecasts to be materialized ratio is 53.07% with an average time for these price targets to be met of 333.64 days.
Most recent stock forecast was given by GREGORY RENZA from RBC on 09-Aug-2022. First documented stock forecast 08-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$68.5
$0.01 (0.01%)
$64
2 years 3 months 14 days ago
(09-Aug-2022)
1/3 (33.33%)
$1.91 (2.87%)
276
Hold
$68.5
$0.01 (0.01%)
2 years 3 months 14 days ago
(09-Aug-2022)
3/4 (75%)
$1.91 (2.87%)
313
Hold
$68.5
$0.01 (0.01%)
$67
2 years 3 months 14 days ago
(09-Aug-2022)
7/9 (77.78%)
$1.91 (2.87%)
825
Hold
$68.5
$0.01 (0.01%)
$133
2 years 3 months 14 days ago
(09-Aug-2022)
1/5 (20%)
$1.91 (2.87%)
567
Hold
$71
2 years 3 months 15 days ago
(08-Aug-2022)
0/1 (0%)
$35.72 (101.25%)
What is GBT (Global Blood Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GBT (Global Blood Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GBT (Global Blood Therapeutics)?
Which analyst is the currently most bullish on GBT (Global Blood Therapeutics)?
Which analyst is the currently most reserved on GBT (Global Blood Therapeutics)?